Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

1.985 -0.115 (-5.48%)
Streaming Delayed Price Updated: 1:07 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,343,419
Open 2.100
Bid (Size) 1.980 (4,300)
Ask (Size) 1.990 (8,200)
Prev. Close 2.100
Today's Range 1.975 - 2.130
52wk Range 1.470 - 3.880
Shares Outstanding 584,908,239
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Mereo BioPharma Group Plc (NASDAQ:MREO) Beats Q3 2025 EPS Estimates, Maintains Cash Runway into 2027 ↗
Mereo BioPharma (MREO) beat Q3 EPS estimates with a narrower loss. The clinical-stage company has cash into 2027 and key data for its lead drug expected soon. 
Via Chartmill
News headline image
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights
From Mereo BioPharma Group plc
Via GlobeNewswire

Performance

YTD
-42.0%
-42.0%
1 Month
+12.1%
+12.1%
3 Month
+12.8%
+12.8%
6 Month
-29.1%
-29.1%
1 Year
-42.5%
-42.5%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks ↗
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
From Pomerantz LLP
Via GlobeNewswire
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Crude Oil Down Over 2%; Delta Air Lines Posts Upbeat Earnings ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Thursday? ↗
Via Chartmill
News headline image
US Stocks Mixed; Initial Jobless Claims Fall ↗
Via Benzinga
News headline image
Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease ↗
Via Investor's Business Daily
News headline image
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Ultragenyx, Mereo Shares Dive As Brittle Bone Disease Drug Misses Early Win ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill

Frequently Asked Questions

Is Mereo BioPharma Group plc - American Depositary Shares publicly traded?
Yes, Mereo BioPharma Group plc - American Depositary Shares is publicly traded.
What exchange does Mereo BioPharma Group plc - American Depositary Shares trade on?
Mereo BioPharma Group plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mereo BioPharma Group plc - American Depositary Shares?
The ticker symbol for Mereo BioPharma Group plc - American Depositary Shares is MREO on the Nasdaq Stock Market
What is the current price of Mereo BioPharma Group plc - American Depositary Shares?
The current price of Mereo BioPharma Group plc - American Depositary Shares is 1.985
When was Mereo BioPharma Group plc - American Depositary Shares last traded?
The last trade of Mereo BioPharma Group plc - American Depositary Shares was at 12/17/25 01:07 PM ET
What is the market capitalization of Mereo BioPharma Group plc - American Depositary Shares?
The market capitalization of Mereo BioPharma Group plc - American Depositary Shares is 1.16B
How many shares of Mereo BioPharma Group plc - American Depositary Shares are outstanding?
Mereo BioPharma Group plc - American Depositary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.